(CWAN) Clearwater Analytics - Overview
Stock: SaaS Platform, Investment Reporting, Risk Analytics, Data Aggregation
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 33.7% |
| Relative Tail Risk | -14.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.37 |
| Alpha | -33.82 |
| Character TTM | |
|---|---|
| Beta | 0.994 |
| Beta Downside | 1.036 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.54% |
| CAGR/Max DD | 0.15 |
Description: CWAN Clearwater Analytics January 09, 2026
Clearwater Analytics Holdings (NYSE:CWAN) delivers a SaaS platform that automates investment data aggregation, reconciliation, accounting, and reporting for a broad client base that includes insurers, asset managers, corporations, institutional investors, and government entities worldwide. Its flagship offering, Clearwater Prism, bundles reporting, data connectors, data-ops, and managed services, while specialized solutions such as LPx (private-fund data) and MLx (mortgage-loan analytics) address niche asset classes. The company also provides the modular JUMP suite for front-, middle-, and back-office functions, and a cloud-based analytics environment for developers and quant teams.
Key market indicators suggest strong tailwinds: the global investment-data-management market is projected to grow at a CAGR of ~12% through 2028, driven by tightening regulatory reporting standards (e.g., SEC Rule 10b-5) and the shift of legacy on-premise systems to cloud SaaS. In Q4 2023 Clearwater reported a 23% year-over-year increase in annual recurring revenue (ARR) to $210 million and a net-retention rate of 115%, reflecting both upsell success and low churn. The firm’s gross margin of ~78% aligns with typical high-margin SaaS peers, while its cash-flow conversion exceeds 90%, underscoring a capital-efficient business model.
For a deeper dive into Clearwater’s valuation dynamics and how they compare to peers, you might explore the analytics on ValueRay to see the latest consensus estimates and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 392.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -16.77 > 1.0 |
| NWC/Revenue: 19.24% < 20% (prev 79.75%; Δ -60.52% < -1%) |
| CFO/TA 0.03 > 3% & CFO 91.4m > Net Income 392.2m |
| Net Debt (822.1m) to EBITDA (60.9m): 13.50 < 3 |
| Current Ratio: 1.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (288.0m) vs 12m ago 24.41% < -2% |
| Gross Margin: 68.53% > 18% (prev 0.72%; Δ 6781 % > 0.5%) |
| Asset Turnover: 35.44% > 50% (prev 68.07%; Δ -32.63% > 0%) |
| Interest Coverage Ratio: 0.05 > 6 (EBITDA TTM 60.9m / Interest Expense TTM 29.6m) |
Altman Z'' 0.85
| A: 0.04 (Total Current Assets 250.8m - Total Current Liabilities 127.6m) / Total Assets 2.99b |
| B: 0.09 (Retained Earnings 261.0m / Total Assets 2.99b) |
| C: 0.00 (EBIT TTM 1.38m / Avg Total Assets 1.81b) |
| D: 0.27 (Book Value of Equity 268.8m / Total Liabilities 989.0m) |
| Altman-Z'' Score: 0.85 = B |
Beneish M -0.96
| DSRI: 0.96 (Receivables 156.8m/108.2m, Revenue 640.4m/424.4m) |
| GMI: 1.05 (GM 68.53% / 72.13%) |
| AQI: 3.68 (AQ_t 0.89 / AQ_t-1 0.24) |
| SGI: 1.51 (Revenue 640.4m / 424.4m) |
| TATA: 0.10 (NI 392.2m - CFO 91.4m) / TA 2.99b) |
| Beneish M-Score: -0.96 (Cap -4..+1) = D |
What is the price of CWAN shares?
Over the past week, the price has changed by -1.08%, over one month by -1.28%, over three months by +42.72% and over the past year by -15.23%.
Is CWAN a buy, sell or hold?
- StrongBuy: 7
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CWAN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.9 | 8.8% |
| Analysts Target Price | 25.9 | 8.8% |
| ValueRay Target Price | 24.1 | 1.3% |
CWAN Fundamental Data Overview February 03, 2026
P/E Forward = 33.8983
P/S = 11.197
P/B = 3.5623
P/EG = 9.9751
Revenue TTM = 640.4m USD
EBIT TTM = 1.38m USD
EBITDA TTM = 60.9m USD
Long Term Debt = 830.9m USD (from longTermDebt, last quarter)
Short Term Debt = 23.5m USD (from shortTermDebt, last quarter)
Debt = 882.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 822.1m USD (from netDebt column, last quarter)
Enterprise Value = 7.99b USD (7.17b + Debt 882.9m - CCE 64.1m)
Interest Coverage Ratio = 0.05 (Ebit TTM 1.38m / Interest Expense TTM 29.6m)
EV/FCF = 97.45x (Enterprise Value 7.99b / FCF TTM 82.0m)
FCF Yield = 1.03% (FCF TTM 82.0m / Enterprise Value 7.99b)
FCF Margin = 12.80% (FCF TTM 82.0m / Revenue TTM 640.4m)
Net Margin = 61.25% (Net Income TTM 392.2m / Revenue TTM 640.4m)
Gross Margin = 68.53% ((Revenue TTM 640.4m - Cost of Revenue TTM 201.5m) / Revenue TTM)
Gross Margin QoQ = 65.56% (prev 65.14%)
Tobins Q-Ratio = 2.67 (Enterprise Value 7.99b / Total Assets 2.99b)
Interest Expense / Debt = 1.83% (Interest Expense 16.1m / Debt 882.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 1.09m (EBIT 1.38m * (1 - 21.00%))
Current Ratio = 1.97 (Total Current Assets 250.8m / Total Current Liabilities 127.6m)
Debt / Equity = 0.45 (Debt 882.9m / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = 13.50 (Net Debt 822.1m / EBITDA 60.9m)
Debt / FCF = 10.03 (Net Debt 822.1m / FCF TTM 82.0m)
Total Stockholder Equity = 1.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.71% (Net Income 392.2m / Total Assets 2.99b)
RoE = 25.83% (Net Income TTM 392.2m / Total Stockholder Equity 1.52b)
RoCE = 0.06% (EBIT 1.38m / Capital Employed (Equity 1.52b + L.T.Debt 830.9m))
RoIC = 0.06% (NOPAT 1.09m / Invested Capital 1.97b)
WACC = 8.69% (E(7.17b)/V(8.05b) * Re(9.58%) + D(882.9m)/V(8.05b) * Rd(1.83%) * (1-Tc(0.21)))
Discount Rate = 9.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.18%
[DCF Debug] Terminal Value 79.06% ; FCFF base≈97.8m ; Y1≈120.7m ; Y5≈205.5m
Fair Price DCF = 7.71 (EV 3.05b - Net Debt 822.1m = Equity 2.23b / Shares 288.6m; r=8.69% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -11.84 | EPS CAGR: -10.37% | SUE: -1.89 | # QB: 0
Revenue Correlation: 95.98 | Revenue CAGR: 33.32% | SUE: 0.52 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.16 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=10
EPS next Year (2026-12-31): EPS=0.04 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+142.1% | Growth Revenue=+29.4%